Delivery Order SPE2DX22D0019-SPE2D825FHT92
- Not listed
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 20, 2025, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is valued at $1,339.07 and carries a firm fixed price structure with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical supply distributor...
- This delivery order, awarded July 21, 2025, represents a $4,038.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion on July 22, 2025,...
- This delivery order, awarded July 28, 2025, represents a $27,577 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain and AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery. The contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support...
- This delivery order, awarded on August 4, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order carries a ceiling value of $10,473.58 with firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This delivery order, awarded on July 21, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00. The delivery order carries a ceiling value of $24,697.26 under firm fixed price terms with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This delivery order, awarded August 12, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order carries a ceiling value of $11,262.65 under firm fixed-price terms and is non-set-aside, competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 29, 2025, with a ceiling value of $1,192.02 and an ultimate completion date of July 30, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is firm fixed price, non-competitive set-aside, and will...
- This delivery order, issued on August 18, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $87,282.36 to supply pharmaceutical products and medical commodities through the Defense Logistics Agency's Medical Supply Chain. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively procured without...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,250.47 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D825FHT92Delivery Order
This delivery order, awarded on August 20, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is valued at $1,640.16 under firm fixed pricing with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was competitively awarded this non-set-aside contract to supply pharmaceutical products and medical supplies to support federal military and healthcare systems. As a prime vendor under the DLA Medical Supply Chain, AmerisourceBergen Drug Corp fulfills critical pharmaceutical procurement needs including brand-name and generic medications, vaccines, specialized medical devices, and healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse medical products ranging from diabetes medications to neurological treatments and pain management pharmaceuticals. This delivery order continues the company's role as a key supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the flexible pharmaceutical prime vendor contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/20/25 |